Tanaka, Tsuyoshi
Suda, Koichi
Shibasaki, Susumu
Serizawa, Akiko
Akimoto, Shingo
Nakauchi, Masaya
Matsuoka, Hiroshi
Inaba, Kazuki
Uyama, Ichiro
Article History
Received: 22 October 2023
Accepted: 4 February 2024
First Online: 15 February 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of Fujita Health University (HM20-265). Written informed consent to perform preoperative chemotherapy followed by minimally invasive gastrectomy was obtained from all individual participants. Informed consent for this retrospective study was obtained through an opt-out method.
: Not applicable. Individual identifying data were not included in this manuscript.
: Tsuyoshi Tanaka, Koichi Suda, Susumu Shibasaki, Akiko Serizawa, Shingo Akimoto, Masaya Nakauchi, Hiroshi Matsuoka, Kazuki Inaba, and Ichiro Uyama do not have conflicts of interest or financial relationships to disclose with regard to the present study. However, I.U. received funding from Medicaroid, Inc. in relation to the Collaborative Laboratory for Research and Development in Advanced Surgical Technology, Fujita Health University. I.U. received advisory fees from Intuitive Surgical, Inc. and Asahi Intecc Co., Ltd., unrelated to the present study and lecture fees from Intuitive Surgical, Inc., Medicaroid Inc., and Medtronic Japan Co., Ltd., unrelated to the submitted work. K.S. received funding from Sysmex, Co. in relation to the Collaborative Laboratory for Research and Development in Advanced Surgical Intelligence, Fujita Health University. K.S. received research expenses from Sysmex, Co., unrelated to the present study and advisory fees from Medicaroid, Inc., unrelated to the submitted work.